miscellaneous:Reacts with sera from 5-25 per cent of cancer patients but not with sera from normal donors. Seventy per cent of renal cancer patients have antibodies against one or a panel of these antigens.,sequence caution:Contaminating sequence. Potential poly-A sequence.,similarity:Belongs to the KCTD3 family.,similarity:Contains 1 BTB (POZ) domain.,similarity:Contains 5 WD repeats.,tissue specificity:Broadly expressed in normal tissues.,
Cell membrane .
Broadly expressed in normal tissues.